<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: aggressive cancer</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Making cancer less cancerous: Blocking a single gene renders tumors less aggressive</title>
   	 <description>Researchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and spread to distant sites. The researchers hope that this so-called &quot;master regulator&quot; gene may be the key to developing a new treatment for tumors resistant to current drugs.</description>
     <link>http://medicalxpress.com/news/2013-05-cancer-cancerous-blocking-gene-tumors.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 May 2013 17:02:44 EST</pubDate>
	 <guid isPermaLink="false">news286732952</guid>
	 
</item>
<item>
     <title>Gauging brain cancer survival time may get easier, study says</title>
   	 <description>(HealthDay)—Life expectancy of people with aggressive brain cancer may be easier to determine with a new method under development at the University of Alabama at Birmingham, researchers say.</description>
     <link>http://medicalxpress.com/news/2013-04-gauging-brain-cancer-survival-easier.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 10 Apr 2013 19:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284834780</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/gaugingbrain.jpg" width="90" height="90" />
</item>
<item>
     <title>Study shows key enzyme missing from aggressive form of breast cancer</title>
   	 <description>A groundbreaking new study led by the University of Kentucky Markey Cancer Center's Dr. Peter Zhou found that triple-negative breast cancer cells are missing a key enzyme that other cancer cells contain—providing insight into potential therapeutic targets to treat the aggressive cancer. Zhou's study is unique in that his lab is the only one in the country to specifically study the metabolic process of triple-negative breast cancer cells.</description>
     <link>http://medicalxpress.com/news/2013-02-key-enzyme-aggressive-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 28 Feb 2013 13:45:04 EST</pubDate>
	 <guid isPermaLink="false">news281281484</guid>
	 
</item>
<item>
     <title>Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets</title>
   	 <description>An extensive genomic study of the childhood cancer neuroblastoma reinforces the challenges in treating the most aggressive forms of this disease. Contrary to expectations, the scientists found relatively few recurrent gene mutations—mutations that would suggest new targets for neuroblastoma treatment. Instead, say the researchers, they have now refocused on how neuroblastoma tumors evolve in response to medicine and other factors.</description>
     <link>http://medicalxpress.com/news/2013-01-tumors-evolve-rapidly-childhood-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Sun, 20 Jan 2013 13:00:27 EST</pubDate>
	 <guid isPermaLink="false">news277901484</guid>
	 
</item>
<item>
     <title>ASH international clinical collaboration replicates high cure rate of APL in developing countries</title>
   	 <description>Data published online today in Blood, the Journal of the American Society of Hematology (ASH) describe the work of an ASH international clinical network collaborative focused on modernizing treatment protocols for patients in the developing world with acute promyeloctyic leukemia (APL) that has drastically improved cure rates in patients in Central and South America, achieving comparable outcomes to those observed in patients in the United States and in Europe.</description>
     <link>http://medicalxpress.com/news/2013-01-ash-international-clinical-collaboration-replicates.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 14 Jan 2013 10:56:03 EST</pubDate>
	 <guid isPermaLink="false">news277383345</guid>
	 
</item>
<item>
     <title>Whitehead scientists identify major flaw in standard approach to global gene expression analysis</title>
   	 <description>Whitehead Institute researchers report that common assumptions employed in the generation and interpretation of data from global gene expression analyses can lead to seriously flawed conclusions about gene activity and cell behavior in a wide range of current biological research.</description>
     <link>http://medicalxpress.com/news/2012-10-whitehead-scientists-major-flaw-standard.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 25 Oct 2012 13:51:19 EST</pubDate>
	 <guid isPermaLink="false">news270391823</guid>
	 
</item>
<item>
     <title>Lack of oxygen in cancer cells leads to growth and metastasis</title>
   	 <description>(Medical Xpress)—It seems as if a tumor deprived of oxygen would shrink. However, numerous studies have shown that tumor hypoxia, in which portions of the tumor have significantly low oxygen concentrations, is in fact linked with more aggressive tumor behavior and poorer prognosis. It's as if rather than succumbing to gently hypoxic conditions, the lack of oxygen commonly created as a tumor outgrows its blood supply signals a tumor to grow and metastasize in search of new oxygen sources – for example, hypoxic bladder cancers are likely to metastasize to the lungs, which is frequently deadly. </description>
     <link>http://medicalxpress.com/news/2012-09-lack-oxygen-cancer-cells-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 13 Sep 2012 11:36:25 EST</pubDate>
	 <guid isPermaLink="false">news266754978</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/lackofoxygen.jpg" width="90" height="90" />
</item>
<item>
     <title>Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas</title>
   	 <description>Researchers at Mayo Clinic have completed the world's first genome-wide sequencing analysis of peripheral T-cell lymphomas, unlocking the genetic secrets of this poorly understood and highly aggressive cancer of the immune system.</description>
     <link>http://medicalxpress.com/news/2012-08-mayo-clinic-genome-wide-analysis-peripheral.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Aug 2012 10:56:11 EST</pubDate>
	 <guid isPermaLink="false">news263037362</guid>
	 
</item>
<item>
     <title>Genetic markers hope for new brain tumor treatments</title>
   	 <description>Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.</description>
     <link>http://medicalxpress.com/news/2012-06-genetic-markers-brain-tumor-treatments.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 15 Jun 2012 11:06:09 EST</pubDate>
	 <guid isPermaLink="false">news258977156</guid>
	 
</item>
<item>
     <title>Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers</title>
   	 <description>We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of cancer. However, until this week, no study had explored the effects of RAL proteins in human cancers &amp;#150; an essential step on the path to developing drugs to target these proteins. From metastasis in bladder cancer, to seminal vessel involvement in prostate cancer, to shortened survival in squamous cell carcinoma, a study published this week in the journal Cancer Research shows that proteins RalA and RalB are associated with aggressive cancer characteristics in human tumors.</description>
     <link>http://medicalxpress.com/news/2012-05-protein-ral-aggressive-characteristics-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 17 May 2012 13:06:47 EST</pubDate>
	 <guid isPermaLink="false">news256478801</guid>
	 
</item>
<item>
     <title>Combination chemotherapy shows benefits for adrenal cancer patients</title>
   	 <description>Endocrinologists at the University of Birmingham have played a key role in a major international clinical trial which has found that giving a combination of chemotherapy drugs to patients suffering from advanced adrenal cancer can help them to live up to a fifth longer.</description>
     <link>http://medicalxpress.com/news/2012-05-combination-chemotherapy-benefits-adrenal-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 04 May 2012 04:31:10 EST</pubDate>
	 <guid isPermaLink="false">news255324652</guid>
	 
</item>
<item>
     <title>Promising developments in early diagnosis and treatment of mesothelioma</title>
   	 <description>New results presented at 3rd European Lung Cancer Conference in Geneva, Switzerland show important steps being made to improve the diagnosis and treatment of malignant pleural mesothelioma, an aggressive cancer of the outer lining of the lungs caused by asbestos exposure.</description>
     <link>http://medicalxpress.com/news/2012-04-early-diagnosis-treatment-mesothelioma.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 Apr 2012 11:16:31 EST</pubDate>
	 <guid isPermaLink="false">news253966584</guid>
	 
</item>
<item>
     <title>Mechanism found connecting metastatic breast cancer and arthritis</title>
   	 <description>Working with mouse models, researchers have found a strong connection between autoimmune arthritis and increased aggressiveness in metastatic breast cancer. The connection appears to involve the tendency of autoimmune arthritis to increase production of mast cells, an immune cell type that increases inflammation and that is prevalent in metastatic tumors. By blocking a key receptor, the researchers were able to affect the interaction between the cancer and mast cells and lessen metastasis.</description>
     <link>http://medicalxpress.com/news/2012-04-mechanism-metastatic-breast-cancer-arthritis.html</link>
	 <category>Immunology</category>
	 <pubDate>Sun, 01 Apr 2012 12:30:35 EST</pubDate>
	 <guid isPermaLink="false">news252502214</guid>
	 
</item>
<item>
     <title>The path to personalized cancer treatment</title>
   	 <description>In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.</description>
     <link>http://medicalxpress.com/news/2012-03-path-personalized-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 28 Mar 2012 13:00:03 EST</pubDate>
	 <guid isPermaLink="false">news252151008</guid>
	 
</item>
<item>
     <title>Longer treatment with cancer drug following removal of GI tumor results in improved survival</title>
   	 <description>Among patients with a high risk of recurrence of a gastrointestinal stromal tumor following surgery for its removal, patients who received imatinib (a drug to treat certain cancers) for 3 years instead of 1 had improved recurrence-free survival and overall survival, according to a study in the March 28 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-03-longer-treatment-cancer-drug-gi.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 27 Mar 2012 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news252082285</guid>
	 
</item>
<item>
     <title>Low bone density medications may have protective effect on endometrial cancer</title>
   	 <description>Low bone density medications, such as Fosamax, Boniva and Actonel, may have a protective effect for endometrial cancer, according to a study at Henry Ford Hospital.</description>
     <link>http://medicalxpress.com/news/2012-03-bone-density-medications-effect-endometrial.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 21 Mar 2012 14:36:04 EST</pubDate>
	 <guid isPermaLink="false">news251559316</guid>
	 
</item>
<item>
     <title>'First-in-human' drug for malignant glioma available in experimental trial</title>
   	 <description>The UC Cancer Institute is one of three centers internationally approved to test an experimental drug's safety and pharmacokinetics and also assess the clinical benefit against recurrent malignant glioma, an aggressive form of brain cancer.</description>
     <link>http://medicalxpress.com/news/2012-02-first-in-human-drug-malignant-glioma-experimental.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 15 Feb 2012 11:58:39 EST</pubDate>
	 <guid isPermaLink="false">news248529502</guid>
	 
</item>
<item>
     <title>US girl, 9, gets six-organ transplant</title>
   	 <description> A nine-year-old girl is making what doctors described as a remarkable recovery Sunday, days after surgeons transplanted six of her organs in a groundbreaking medical procedure.</description>
     <link>http://medicalxpress.com/news/2012-02-girl-six-organ-transplant.html</link>
	 <category>Other</category>
	 <pubDate>Sun, 05 Feb 2012 14:51:49 EST</pubDate>
	 <guid isPermaLink="false">news247675832</guid>
	 
</item>
<item>
     <title>Breaking oncogene's hold on cancer cell provides new treatment direction</title>
   	 <description>Just as people's bodies and minds can become addicted to substances such as drugs, caffeine, alcohol, their cancers can become addicted to certain genes that insure their continued growth and dominance.</description>
     <link>http://medicalxpress.com/news/2011-12-oncogene-cancer-cell-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 08 Dec 2011 14:00:02 EST</pubDate>
	 <guid isPermaLink="false">news242573362</guid>
	 
</item>
<item>
     <title>New research gives hope to women with deadliest breast cancer</title>
   	 <description>Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.</description>
     <link>http://medicalxpress.com/news/2011-11-women-deadliest-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 14 Nov 2011 11:25:22 EST</pubDate>
	 <guid isPermaLink="false">news240492310</guid>
	 
</item>
<item>
     <title>Australian man sues over surgical mistake</title>
   	 <description> An Australian man endured seven rounds of chemotherapy and had 80 percent of his stomach removed after being told he had cancer, only to later learn it was a misdiagnosis, reports said Sunday.</description>
     <link>http://medicalxpress.com/news/2011-11-australian-sues-surgical.html</link>
	 <category>Other</category>
	 <pubDate>Sun, 13 Nov 2011 06:36:32 EST</pubDate>
	 <guid isPermaLink="false">news240388581</guid>
	 
</item>
<item>
     <title>Cell movement provides clues to aggressive breast cancer</title>
   	 <description>Researchers from the University of Michigan Comprehensive Cancer Center have identified a specific molecule that alters how breast cancer cells move. This affects the cells' ability to spread or metastasize to distant parts of the body, the hallmark of deadly, aggressive cancer.</description>
     <link>http://medicalxpress.com/news/2011-10-cell-movement-clues-aggressive-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 03 Oct 2011 11:47:08 EST</pubDate>
	 <guid isPermaLink="false">news236861210</guid>
	 
</item>
<item>
     <title>Test could detect breast cancers earlier in young, high-risk African-American women</title>
   	 <description>Certain cancer signaling pathways that are activated in aggressive cancer can be detected very early, even in precancerous cells, among young African-American women at high risk for breast cancer. This may allow for earlier detection and prevention of cancer.</description>
     <link>http://medicalxpress.com/news/2011-09-breast-cancers-earlier-young-high-risk.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 20 Sep 2011 12:08:01 EST</pubDate>
	 <guid isPermaLink="false">news235739250</guid>
	 
</item>
<item>
     <title>Uncovering the spread of deadly cancer</title>
   	 <description>For the first time, scientists can see pathways to stop a deadly brain cancer in its tracks. Researchers at Case Western Reserve University School of Medicine have imaged individual cancer cells and the routes they travel as the tumor spreads.</description>
     <link>http://medicalxpress.com/news/2011-08-uncovering-deadly-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 26 Aug 2011 10:38:11 EST</pubDate>
	 <guid isPermaLink="false">news233573873</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/2-uncoveringth.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists identify overactive genes in aggressive breast cancers</title>
   	 <description>Scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.</description>
     <link>http://medicalxpress.com/news/2011-06-scientists-overactive-genes-aggressive-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Jun 2011 12:14:51 EST</pubDate>
	 <guid isPermaLink="false">news226149269</guid>
	 
</item>


</channel>
</rss>
